# T790M Mutation Positive 2nd Line STandard of cAre Registry

> **NCT02368990** · — · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02368990
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Since the conception of the study, the competitive environment has developed and as a result this study is no longer able to generate the necessary information.
- **Last updated:** 2015-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02368990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02368990, "T790M Mutation Positive 2nd Line STandard of cAre Registry". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02368990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*